US5047229A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Treatment of cardiovascular and cerebral toxicity using calcium modulators
Assignee: Bayer Corp
•
Filing: 1986-12-17
•
Granted: 1991-09-10
•
Expires: 2006-12-17
Abstract
Abstract Calcium modulators can be effectively used to treat cardiovascular and cerebral toxicity induced by materials that alter the normal interaction of neurotransmitters with the calcium transport mechanisms of myocardial and cerebral cells. For example, calcium modulators can be used as an antidote to the lethal and chronic toxicity of cocaine and related indirectly acting sympathomimetic amines, imipramine and other tricyclic antidepressants, ganglionic stimulating drugs, and other toxic substances such as organophosphorus compounds that cause accumulations of neurotransmitters. Calcium modulators can also be used as an antidote to substances whose toxicity is based upon anticholinesterase activity. In addition, calcium modulators can be used as antagonists to the various types of toxic substances.
Inventors
- 👤 Gabriel G. Nahas
- 👤 Renaud Trouve
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 01:41
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/55; A61K31/13; A61K31/135; A61K31/275; A61K31/40; A61K31/435; A61K31/44; A61K31/445; A61K31/46; A61K31/495; A61K45/00; A61K45/06
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
64 words
A method for treating cardiovascular toxicity induced by a tricyclic antidepressant that induces a toxic effect by altering the normal interaction of neurotransmitters with the calcium ion metabolism of myocardial cells, comprising administering to a host intoxicated with the toxic material a compound which inhibits constriction of arteries in vitro in the presence of a neurotransmitter in an amount effective to treat the toxicity.
Claim 2
Independent Claim
64 words
A method for treating cardiovascular toxicity induced by a tricyclic antidepressant that induces a toxic effect by altering the normal interaction of neurotransmitters with the calcium ion metabolism of myocardial cells, comprising administering to a host intoxicated with the toxic material a compound which inhibits constriction of arteries in vitro in the presence of a neurotransmitter in an amount effective to treat the toxicity.
Claim 3
Dependent Claim
30 words
A method according to claim 1, wherein the compound administered is selected from the group consisting of verapamil, bepridil, nifedipine, diltiazem, cinnarizine, flunarizine, perhexiline, prenylamine, nitrendipine, nimodipine, nicardipine, and lidoflazine.
Claim 4
Independent Claim
64 words
A method for treating cerebral toxicity induced by a tricyclic antidepressant that induces a toxic effect by altering the normal interaction of neurotransmitters with the calcium ion metabolism of cerebral cells, comprising administering to a host intoxicated with the toxic material a compound which inhibits constriction of arteries in vitro in the presence of a neurotransmitter in an amount effective to treat the toxicity.
Claim 5
Independent Claim
64 words
A method for treating cerebral toxicity induced by a tricyclic antidepressant that induces a toxic effect by altering the normal interaction of neurotransmitters with the calcium ion metabolism of cerebral cells, comprising administering to a host intoxicated with the toxic material a compound which inhibits constriction of arteries in vitro in the presence of a neurotransmitter in an amount effective to treat the toxicity.
Claim 6
Dependent Claim
30 words
A method according to claim 3, wherein the compound administered is selected from the group consisting of verapamil, bepridil, nifedipine, diltiazem, cinnarizine, flunarizine, perhexiline, prenylamine, nitrendipine, nimodipine, nicardipine, and lidoflazine.
Claim 7
Dependent Claim
19 words
A method according to claim 1, wherein the host is intoxicated with a lethal dose of the toxic material.
Claim 8
Dependent Claim
19 words
A method according to claim 3, wherein the host is intoxicated with a lethal dose of the toxic material.
Claim 9
Dependent Claim
14 words
A method according to claim 1, wherein the compound administered is nimodipine or flunarizine.
Claim 10
Dependent Claim
14 words
A method according to claim 1, wherein the compound administered is nimodipine or flunarizine.
Claim 11
Independent Claim
40 words
A method for treating cardiovascular toxicity induced by imipramine comprising administering to a host intoxicated with imipramine a compound which inhibits constriction of arteries in vivo in the presence of a neurotransmitter in an amount effective to treat the toxicity.
Claim 12
Independent Claim
40 words
A method for treating cardiovascular toxicity induced by imipramine comprising administering to a host intoxicated with imipramine a compound which inhibits constriction of arteries in vivo in the presence of a neurotransmitter in an amount effective to treat the toxicity.
Claim 13
Dependent Claim
30 words
A method according to claim 9, wherein the compound administered is selected from the group consisting of verapamil, bepridil, nifedipine, diltiazem, cinnarizine, flunarizine, perhexiline, prenylamine, nitrendipine, nimodipine, nicardipine, and lidoflazine.
Claim 14
Independent Claim
40 words
A method for treating cerebral toxicity induced by imipramine comprising administering to a host intoxicated with imipramine a compound which inhibits constriction of arteries in vivo in the presence of a neurotransmitter in an amount effective to treat the toxicity.
Claim 15
Independent Claim
40 words
A method for treating cerebral toxicity induced by imipramine comprising administering to a host intoxicated with imipramine a compound which inhibits constriction of arteries in vivo in the presence of a neurotransmitter in an amount effective to treat the toxicity.
Claim 16
Dependent Claim
30 words
A method according to claim 11, wherein the compound administered is selected from the group consisting of verapamil, bepridil, nifedipine, diltiazem, cinnarizine, flunarizine, perhexiline, prenylamine, nitrendipine, nimodipine, nicardipine, and lidoflazine.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-09-09 | 1995-03-11 | 1995-09-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-09-09 | 1999-03-11 | 1999-09-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-09-09 | 2003-03-11 | 2003-09-10 | $7700.00 | Window Closed / Lapsed |